Meropenem B. Braun

Meropenem, the active ingredient in Meropenem B. Braun, is a carbapenem presented as a sterile powder for intravenous use. It treats severe bacterial infections in hospitalized patients.

GNH USA supplies Meropenem B. Braun as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

Meropenem is a broad‑spectrum carbapenem used for serious infections caused by susceptible bacteria.

- Complicated intra‑abdominal infections: provides bactericidal activity against mixed aerobic and anaerobic pathogens. - Hospital‑acquired pneumonia, including ventilator‑associated pneumonia: targets resistant Gram‑negative and Gram‑positive organisms. - Complicated urinary tract infections: eradicates Enterobacteriaceae and Pseudomonas species. - Bacterial meningitis: penetrates the cerebrospinal fluid to treat meningitic pathogens. - Sepsis and septic shock: offers rapid bacterial clearance in critically ill patients.

Adverse reactions may occur with meropenem therapy and are categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be watery and self‑limiting. - Headache: transient and usually resolves without intervention. - Injection site pain: discomfort at the intravenous site. - Elevated liver enzymes: mild, reversible changes in hepatic function.

Serious or Rare Side Effects: - Seizures: especially in patients with renal impairment or CNS disorders. - Severe allergic reactions: including anaphylaxis and rash. - Clostridioides difficile colitis: may cause severe diarrhea. - Thrombocytopenia: reduced platelet count requiring monitoring. - Acute kidney injury: potential renal function decline.

When using meropenem, clinicians should consider several safety measures.

- Renal function: adjust dose in patients with impaired kidney function. - CNS disorders: monitor for neurotoxicity, especially seizures. - Allergy history: avoid in patients with known carbapenem hypersensitivity. - Pregnancy and lactation: use only if clearly needed, as safety data are limited. - Concomitant antibiotics: assess for additive toxicity. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Meropenem may interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Valproic acid: risk of decreased plasma levels and loss of seizure control. - Probenecid: may increase meropenem concentrations, raising toxicity risk.

Moderate Interactions (Monitor Closely): - Aminoglycosides: additive nephrotoxicity; monitor renal function. - Loop diuretics: potential for electrolyte disturbances; observe serum levels. - Warfarin: possible alteration of INR; check coagulation parameters regularly.